Company · founded 2004
BioMimetic Systems (United States)
Cambridge, United States · biomimetic-systems.com
- Citations, last 5 years
- 23
- Works, last 5 years
- 10
- h-index
- 10
- Scientists listed
- 0
- Grants since 2016
- 13
Grants received
2021–2023 · research · R43
Green and Sustainable in situ Remediation of Heavy Metals Contaminated Soils and Aqueous Systems
Nadia Adam · BioMimetic Systems (United States) · funded by National Institutes of Health
2020–2021 · grant · Standard Grant
SBIR Phase I: Broad Spectrum biorational bio- and synthetic insecticides and mosquito repellents
Nadia Adam · BioMimetic Systems (United States) · funded by National Science Foundation
2019–2021 · research · R41
Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke.
David Warner · BioMimetic Systems (United States) · funded by National Institutes of Health
2019–2021 · research · R41
Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke.
David Warner · BioMimetic Systems (United States) · funded by National Institutes of Health
2018–2022 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
David S. Silberstein · BioMimetic Systems (United States) · funded by National Institutes of Health
2018–2019 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
David S. Silberstein · BioMimetic Systems (United States) · funded by National Institutes of Health
2018–2023 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
David S. Silberstein · BioMimetic Systems (United States) · funded by National Institutes of Health
2018–2021 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases.
David S. Silberstein · BioMimetic Systems (United States) · funded by National Institutes of Health
2017–2018 · grant · Standard Grant
SBIR Phase I: Novel Biomimetic Production of Broad-Spectrum Fungicide BioSurF-I
Nadia Adam · BioMimetic Systems (United States) · funded by National Science Foundation
2015–2023 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
James D Crapo · BioMimetic Systems (United States) · funded by National Institutes of Health
2015–2022 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
James D Crapo · BioMimetic Systems (United States) · funded by National Institutes of Health
2015–2023 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
James D Crapo · BioMimetic Systems (United States) · funded by National Institutes of Health
2015–2020 · research · R44
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
James D Crapo · BioMimetic Systems (United States) · funded by National Institutes of Health